Avanir Pharmaceuticals, which previously said the FDA had questions about “human factor” study data for a migraine treatment, said it will provide new data.
WSJ.com: US Business, Wall Street Journal: Business
Wed, 11/26/2014 - 4:13pm
Avanir Pharmaceuticals, which previously said the FDA had questions about “human factor” study data for a migraine treatment, said it will provide new data.